An in vitro gut-immune co-culture model with apical and basal accessibility, designed to more closely resemble a human intestinal microenvironment, was employed to study the role of the Nlinked protein glycosylation (Pgl) pathway in Campylobacter jejuni pathogenicity. The gutimmune co-culture (GIC) was developed to model important aspects of the human small intestine by the inclusion of mucin producing goblet cells, human enterocytes, and dendritic cells, bringing together a mucus-containing epithelial monolayer with elements of the innate immune system. The utility of the system was demonstrated by characterizing host-pathogen interactions facilitated by N-linked glycosylation, such as host epithelial barrier functions, bacterial invasion and immunogenicity. Changes in human intestinal barrier functions in the presence of 11168 C. jejuni (wildtype) strains were quantified using GICs. The glycosylationdeficient strain 11168 ΔpglE was 100-fold less capable of adhering to and invading this intestinal model in cell infectivity assays. Quantification of inflammatory signaling revealed
Introduction
The Gram-negative pathogen Campylobacter jejuni is a leading cause of gastroenteritis and diarrheal disease. Infections can be severe, especially in children, the elderly and immunocompromised individuals, with infection leading to fatality in 1 in 3,000 cases by some estimates (Ternhag et al. 2005) . It has been suggested that adhesion to and invasion of host epithelial cells is critical for disease development (Young, 2007) . C. jejuni has been shown to transcellularly invade intestinal epithelial cells, becoming encased in vacuoles that protect them from lysosomal degradation and immune detection (Dorrell et al. 2001 ) (Watson and Galan 2008) . Characterization of the roles of virulence determinants in adhesion and invasion is crucial for identification of pathways, enzymes, and molecules to target for therapeutic intervention. This is of particular importance in the era of antimicrobial resistance, where additional insight into the contributors to microbial pathogenicity would allow for investigation of anti-virulence agents that may be less likely to elicit such resistance. Many virulence factors have been associated with host cell invasion, including flagellar motility and chemotaxis, outer membrane vesicles, adhesins and proteases.
One such determinant of microbial pathogenicity is protein glycosylation (Lu et al. 2015) .
The global significance of N-linked glycosylation in C. jejuni is not yet fully understood, however a correlation between N-linked protein glycosylation and virulence has been demonstrated in avian models of infection and in vitro mammalian systems. The N-linked protein glycosylation (pgl) operon and N-glycan of C. jejuni are illustrated in Fig 1A. Cecal analysis of chick intestines has shown significantly-decreased C. jejuni colonization upon individual knockouts of pglB, pglD, pglE, pglH and pglK genes (Jones et al. 2004 , Kelly et al. 2006 . Additionally studies of 81-176 C. jejuni in murine models have revealed similar decreases in colonization by pglB and pglE knockouts (SzymanskiBurr et al. 2002) . In vitro studies of the Pgl pathway and its role in virulence have also been carried out in unpolarized monolayers of HeLa (MacCallum et al. 2005) , INT 407 (MacCallumHaddock et al. 2005) , T84 MacCallumHaddock et al. (2005) , and mucus-secreting HT29 (Bahrami et al. 2011 . However, these systems do not feature tight junctions, brush borders or other important components of intestinal epithelia (Backert et al. 2013) . Additionally, studies of infectivity on polarized monolayers of human epithelial colorectal adenocarcinoma (Caco-2) (Hu et al. 2008 ) do not account for the intestinal mucosal layer and its barrier functions, which in some strains of C. jejuni has been shown to play a role in bacterial motility (Ferrero and Lee 1988) and assist in binding and invasion of host cells (Szymanski et al. 1995) . Bacterial interactions with mucosal components of the gut have also been shown to be an important part of virulence behaviors, in some cases influencing whether C. jejuni acts as a commensal as seen in chickens and other animals, or as a pathogen as seen in humans (Alemka et al. 2010 , Alemka et al. 2012 . Although these in vitro studies on components of human intestinal physiology have provided valuable insight, a more comprehensive understanding of the mechanism and determinants of C. jejuni pathogenicity could be potentially achieved with model systems incorporating several aspects and more closely resembling human gut physiology.
To address this need, herein we present the adaptation and application of a gut-immune co-culture model (GIC, Figure 2 ), engineered to mirror important aspects of native human small intestinal tissue including barrier functions and pharmacological properties , Edington et al. 2018 , Louwen et al. 2012 , Tsamandouras et al. 2017 , for the characterization of C. jejuni N-linked glycans in host-pathogen interactions. Each GIC contains an epithelial monolayer comprising a 9:1 ratio of absorptive human enterocytes (C2BBe1) and human mucin-producing goblet cells (HT29-MTX) seeded and grown on a permeable Transwell insert. The C2BBe1 cell line was chosen for its ability to form a brush border morphologically comparable to that of human colon, with heterogeneous microvillar presentation. Dendritic cells, derived by in vitro differentiation of primary human monocytes, were present on the basolateral face of the Transwell insert at approximately a 1:10 ratio to epithelial cells in the mature monolayer. Thus, each GIC unites a polarized human intestinal epithelial monolayer and dendritic cells, bringing together a mucus-bearing gut with essential elements of the innate immune system. This gut-immune co-culture model was used to quantify the impact of C. jejuni infection on different aspects of human intestinal function, such as barrier integrity, mucus production and innate immune system activation, and the importance of N-glycosylation in these host-pathogen interactions. We anticipate that the application of the gut-immune model to the characterization of this recalcitrant microaerophilic organism will advance studies of the pathogen in a relevant, quantitative multidimensional platform.
Results
To demonstrate the utility of the gut-immune model for glycobiological studies of bacterial pathogenicity, the impact of C. jejuni N-glycosylation was characterized and quantified using several analytical readouts of the gut-immune model, listed in Figure 2 . In these studies, the apical face of GICs was challenged with wildtype NCTC 11168 C. jejuni or a 11168ΔpglE strain (Linton et al. 2002) , which exhibits near-complete abolition of N-linked protein glycosylation.
( Fig S1) .
It was initially unclear whether this fastidious microaerophilic organism, typically cultured to low optical densities in Mueller Hinton broth under 85% N2, 5% O2 and 10% CO2, would be viable or culturable during and after prolonged studies on GICs. Conversely, it was unknown if the nutrient-rich GIC growth media would cause bacterial overgrowth. However, culture conditions, multiplicities of infection and experimental time frames were identified that support bacterial and intestinal cell survival that would allow for measurements to be taken of both bacterial and mammalian processes.
Using these conditions, we characterized the impact of C. jejuni infection on aspects of GIC epithelial barrier integrity and probed the role of N-glycosylation. GICs were challenged with wildtype NCTC 11168 C. jejuni or 11168ΔpglE and intestinal secreted mucin content was examined. As shown in Figure 3A , the presence of both wildtype and ΔpglE C. jejuni resulted in a significant reduction of secreted mucins associated with the monolayer as compared with uninfected GICs. Next, changes in the barrier integrity in response to infection were quantified by Lucifer yellow permeability, measuring apical-to-basal transport of dye to indicate paracellular permeability in response to infection (Angelis and Turco 2011). In contrast to wildtype, which showed modest changes in barrier function, infection with ΔpglE resulted in significantly increased monolayer permeability ( Fig 3B) .
Next, as pathogen/host association and invasion are primary hallmarks of C. jejuni infection in vivo, we quantified these behaviors in the GIC. In this analysis, a nearly 100-fold decrease in bacterial association with the epithelial monolayer between wildtype and ΔpglE was observed ( Fig 3C) . Monolayer infection was also quantified after gentamycin treatment of the apical compartment, killing all bacteria except those within cells, and a similar difference between wildtype and ΔpglE infectivity was observed. Additionally, a statistically-significant, but modest, 2.4-fold decrease in adhesion and invasion of wildtype C. jejuni was observed ( Fig   3D) following treatment of monolayers with 2 mM free reducing heptasaccharide from C. jejuni, shown in Figure 1 . Competition between soluble C. jejuni N-glycan, also known as free oligosaccharide or FOS (Dwivedi et al. 2013) , and wildtype C. jejuni suggests a molecular role for the N-glycan in the adhesion and invasion of host intestinal cells.
A major advantage of the gut-immune model for studying C. jejuni pathogenicity is its utility in quantifying both intestinal epithelium inflammation and the resulting inflammatory 
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) and 81-176 C. jejuni (Lindmark et al. 2009 ) have been shown to contain cytolethal distending toxin, and are hypothesized to be the primary mechanism of toxin delivery to the host.
To study the role of the pgl locus on the behavior of this important C. jejuni virulence factor, OMVs were isolated from cultures of 11168 and 11168ΔpglE C. jejuni and analyzed for glycoprotein content by immunoblotting. A significant loss of N-linked glycoproteins was observed in OMVs isolated from ΔpglE when compared to wildtype ( A useful feature of GICs is the ability to vary composition of the apical epithelial monolayer according to investigator needs, while maintaining dendritic cells in the basolateral compartment. To study the functions of glycosylated and non-glycosylated C. jejuni OMV, barrier function and inflammation were measured on GICs lacking goblet cells and dendritic cells to ensure effective vesicle-epithelial cell contact. C2bbe1 monolayers were treated with 100 μg doses of OMVs from both strains and showed no change in barrier integrity by TEER ( Fig.   S3 ). However, IL-8, CXCL1, and several other immune markers were secreted by these GICs in response to OMV treatment ( Fig S4) . Importantly, these results illustrate the utility of GICs in quantitatively characterizing several aspects of virulence factor function such as those exhibited by C.jejuni OMV.
Discussion and Conclusions.
Use of the gut-immune model allows for convenient and simultaneous measurement of physiological and immunological responses to infection by C. jejuni, whose protein glycosylation pathway has been shown to be important in pathogenicity. We anticipate that this model system will be a valuable alternative for studying interactions of C. jejuni and other enteropathogens with host cells. These studies also show that GICs can be interfaced with microaerophilic pathogens such as C. jejuni for periods of time amenable to immunological study and under conventional culture conditions in normoxia and may be used to study other facets of this cell-cell interaction. Furthermore, the presented conditions should be readily adaptable to the study of other "difficult-to-culture" Gram-negative pathogens (e.g. Helicobacter pylori).
The analyses revealed some of the relationships between C. jejuni N-glycosylation and pathogenicity. Soluble mucin content on GICs ( Fig 3A) was largely depleted during incubation with C. jejuni -a finding not previously quantified. The reduction of monolayer integrity ( Fig   3B) was also directly correlated with loss of bacterial N-glycosylation and could be explained by a concomitant increase in proteases within ΔpglE OMVs capable of cleaving tight-junction proteins ( Fig. 4D) . Importantly, the degree of C. jejuni adhesion and invasion in the GICs directly correlated with global N-linked protein glycosylation and infectivity ( Fig 3C) .
Although direct release of cytokines by non-polarized and polarized epithelial monolayers and dendritic cells has been reported separately in response to wildtype C. jejuni exposure, this is the first characterization of the impact of the Pgl pathway on cytokine response in the intestinal epithelium in synergy with basolateral innate immune cells, with many cytokines and chemokines that were measured not previously reported in studies of C. jejuni infection.
Here, it appears that basolateral inflammatory cytokine and chemokine secretion was modestly increased when the GICs were infected with the ΔpglE strain as compared to wildtype ( Fig 4A) .
These cytokine profiles are likely dominated by factors produced by dendritic cells with some contribution from the epithelial cells; however, the exact contribution from each cell types is difficult to ascertain given the highly synergistic nature of the multicellular crosstalk. Finally, the glycosylation state of isolated wildtype and ΔpglE OMV did not change the inherent immunogenicity on C2bbe1-only GICs (Fig S4) , and thus may not have a role in the loss of infectivity upon loss of glycosylation. However, it will be important to further characterize these virulence factors using other readouts provided by the gut-immune model.
In conclusion, the tripartite design of the gut-immune model, containing a recapitulated human intestinal epithelium and innate immune component, allowed for examination of the various roles played by the gut monolayer, the mucus, and dendritic cells and highlighted the importance of proper N-glycan presentation in various aspects of C. jejuni infectivity. This system also provided an opportunity to study the physiological and inflammatory interplay between all of the host components when exposed to this pathogen and its virulence factorssuch insights would have otherwise been unobservable in other culture models. We anticipate this system will be advantageously applied to the study of other enteropathogens or aspects of pathogenic interactions. Equal amounts of whole cell lysates of wildtype and ΔpglE C. jejuni were analyzed by immunoblotting, probing with rabbit anti-N-glycan antibodies. Secondary staining was performed with anti-rabbit Licor IrDye 800 antibodies and blots imaged using an Odyssey Infrared Imaging system. Lanes: m: molecular weight markers, 1: 11168 C. jejuni, 2: 11168, 3: 11168 ΔpglE. Lysate amounts were normalized by protein concentration, determined by Pierce BCA assay kit (Thermo Fisher Scientific, Waltham, MA.) Figure S2 . Treatment of GICs with C. jejuni results in synergistic release of several cytokines and chemokines into basal media by the epithelium and adjacent dendritic cells. GICs were inoculated with vehicle, 11168 C. jejuni, or 11168ΔpglE and incubated for 24 h. Basolateral media was sampled and inflammatory molecules quantified by 40-plex immunoassay. Bars show the mean of four independent replicates, with error bars showing one standard deviation. Mean marker concentrations in 11168 and 11168ΔpglE samples were compared to untreated gut MPSs and each other via 1-way ANOVA with no correction for multiple comparisons. P values for each statistically significant comparison are shown in each legend.
Figure S3. OMV from 11168 C. jejuni and variant do not provoke measurable changes in barrier integrity by TEER.
Barrier integrity of each C2BBe1-only GIC was quantified by transepithelial electrical resistance (TEER) measurements at the start of the experiment. GICs were treated with vehicle, 100 μg OMV isolated from 11168 C. jejuni, or 100 μg 11168ΔpglE OMV and incubated at 37 °C for 24 h. After incubation, TEER values were again measured for all monolayers and the apical media was sampled for immunoassay analysis. Data shown are the average of three independent replicates, with error bars denoting one standard deviation. The mean is shown by a longer horizontal bar. Fig S4. OMV from 11168 C. jejuni provoke an immune response from gut epithelia. GICs were treated with vehicle alone, 100 μg OMV isolated from 11168 C. jejuni, or 100 μg 11168ΔpglE OMV, followed by incubation for 24 h. Apical media from all GICs was sampled and cytokines and chemokines present quantified by multiplexed immunoassay. Data shown are the average of three independent replicates, in technical duplicate, with error bars denoting one standard deviation. Mean marker concentrations in 11168 OMV and 11168ΔpglE OMV samples were compared to uninfected GICs and each other via 1-way ANOVA with no correction for multiple comparisons. * indicates statistically significant differences with absolute P-values ≤0.05, ** indicates P≤0.01, *** indicates P≤0.001.
Materials and Methods

General information
All common chemicals, gases and reagents were purchased from Sigma-Aldrich, AirGas, Fisher Scientific and VWR unless otherwise noted. Following is a list of the sources of other key reagents and expendable materials used in these studies: BBL Mueller-Hinton broth (BD and Co., Cat. No. 211443 
Tissue culture media compositions
Generalized Procedure A: Culture of C. jejuni strains
Samples from glycerol stocks of C. jejuni (NCTC 11168 or 11168ΔpglE) were streaked onto MH agar plates containing selection antibiotics (10 µg/mL trimethoprim for 11168 wildtype, 10 µg/mL trimethoprim and 20 µg/mL kanamycin sulfate for 11168ΔpglE). Plates were placed inside a plastic pouch (along with an atmospheric CO2 indicator) and purged with a microaerophilic gas mixture (85% N2, 10% CO2, 5% O2) multiple times until the correct concentration of CO2 was reached. Sealed pouches were then incubated at 37 °C for 24 h, after which colonies were taken up in 3 mL of PBS broth. Cells taken from these master stocks of C. jejuni were utilized in the subsequent experiments.
Generalized Procedure B: Maintenance and passaging of intestinal epithelial cell lines
C2BBe1 and HT29-MTX C2BBe1 (ATCC, passage 48-58) and HT29-MTX (Sigma, passage 20-30) were maintained with Gut Cell Line Media in separate 75 cm 2 flasks. Cells at 80-90% confluence were passaged by washing with PBS without calcium and magnesium (PBS-/-) and lifting with 0.25% trypsin-EDTA at 37°C. After 10 minutes, cells were manually dissociated, quenched with media, and centrifuged at 300 x g for 5 min in 15 mL conical tubes. After, cells were resuspended and quantified by Trypan Blue exclusion for continued passaging or seeding into Transwell membrane inserts according to Generalized Procedures C and D. Passages of C2BBe1 and HT29-MTX were seeded with 6 x10 5 and 2 x10 6 cells, respectively, every 6-7 days and were fed with Gut Cell Line Medium every 2-3 days.
Generalized Procedure C: Preparation and maintenance of polarized epithelial monolayers
Polarized epithelial monolayers were prepared as previously described ). Prior to seeding, Transwell membrane inserts were coated with 50 mg/mL rat tail collagen I (Corning, Cat No. 354236) in PBS-/-for 2 h at rt. Intestinal epithelial cells were collected according Generalized Procedure B, ensuring cells had been passaged twice post-thawing prior to use. For C2BBe1-only monolayers, after rinsing away collagen coating solution with Advanced DMEM, 1.12 x 10 5 C2BBe1 cells (10 5 cells/cm 2 ) were seeded in each insert in 500 μL of Gut Seeding Media to form C2BBe1 monolayers. For C2BBe1/HT29-MTX monolayers, cells seeded on inserts were a 9:1 mixture of the C2BBe1 and HT29-MTX cell lines. All inserts were fed every 2-3 days with 500 μL and 1.5 mL Gut Insert Seeding media in apical and basolateral chambers, respectively. From Day 7 on, inserts were fed every 2-3 days with Serum-Free Insert Medium. Inserts were cultured in this manner for 21-27 days before use in any experiments.
Generalized Procedure D: Immune cell isolation, differentiation and seeding
Peripheral blood mononuclear cells (PBMCs) were processed from Leukopak (STEMCELL Technologies, Cat. No. 70500) using the recommended protocol for cell isolation without density centrifugation. Isolated cells were aliquoted and stored in liquid nitrogen.
To derive dendritic cells, monocytes were isolated from thawed PBMCs using the EasySep Human Monocyte Enrichment Kit without CD16 Depletion (STEMCELL Technologies, Cat. No. 19058) . The purified monocytes were seeded into a 24-well tissue culture treated plate at ~1.2 million cells/well in Advanced RPMI medium (Gibco, Cat. No. 12633-012) supplemented with 1X GlutaMax, 1% P/S, 50 ng/mL GM-CSF (Biolegend, Cat. No. 572903), 35 ng/mL IL-4 (Biolegend Cat. No. 574004 ) and 10 nM retinoic acid. After 7 days of differentiation (at day 19-20 of the epithelial culture), mature dendritic cells were lifted using PBS-/-and Accutase (Gibco, Cat. No. A11105-01) and seeded onto the basolateral side of inverted gut Transwell inserts at 10 5 /insert, allowing 2 h for attachment.
Preparation of retinoic acid stock solution
Retinoic acid was dissolved in 200 proof EtOH and concentration was determined by measuring absorbance at 350 nm (εmax (EtOH) = 44,300 M -1 cm -1 ). The solution was diluted to 50μM in PBS-/-with 1% BSA. Frozen stocks were kept at -20°C for up to 3 months.
Generalized Procedure E: Preparation of gut-immune co-cultures (GICs)
To begin, intestinal epithelia were prepared as described in Generalized Procedure C. At Day 13, monocytes were isolated and differentiated as in Generalized Procedure D. On Day 20 post-monolayer seeding (7 days postmonocyte isolation), dendritic cells were recovered and seeded onto the basal membrane of the gut cultures. From this point, gut-immune co-cultures were maintained with 500μL Apical Media and 1.5 mL Basal Media in their respective chambers. GICs were utilized in experiments 21 days post-monolayer seeding. GICs were rinsed with Serum-Free Maintenance Media without antibiotics prior to inoculation with C. jejuni.
Generalized Procedure F: Treatment of GICs with strains and mutants of C. jejuni
The apical compartment of GICs containing gut epithelial monolayers or co-cultures were inoculated with C. jejuni strains and mutants ahead of experiments characterizing bacterial adhesion and internalization under various conditions and ahead of immunoassays and other measures of epithelial health. To begin, C. jejuni stocks were prepared according to General Procedure A and aliquots sufficient to give an OD = 1.0 in 1 mL were taken into microcentrifuge tubes. Cells were centrifuged at 16,000 x g for two minutes to give a pellet (pink in color,) the supernatant removed and the pellet resuspended in 1 mL DPBS. Apical growth media without P/S was warmed to 37 °C and inoculated with washed C. jejuni to give a solution with initial OD of 0.03 (multiplicity of infection: 10) or 0.15 (multiplicity of infection: 50). GICs to be treated were provided fresh basal growth media right before innoculation. Growth media was aspirated from the apical face of each GIC to be treated and replaced with 500 µL of media containing C. jejuni strains.
Measurement of bacterial adhesion adhesion to GIC epithelia
GICs inoculated with wildtype C. jejuni NCTC 11168 or 11168ΔpglE according to General Procedure F were incubated at 37 °C for 24 h, after which inserts were visually inspected and apical compartments washed four times with 500 µL DPBS to remove non-adherent bacteria. GICs were given 500 µL DPBS with 0.1% Triton and placed on an orbital shaker shaking at 300 rpm for 20 min to lyse epithelial monolayers. Lysates containing bacteria from monolayer surfaces and cell interiors were serially diluted in MH broth and 50 µL plated on MH agar containing appropriate selection antibiotics for colony counting.
Measurement of invasion by C. jejuni into epithelial monolayers by gentamycin treatment
GICs inoculated with wildtype C. jejuni NCTC 11168, or 11168ΔpglE according to General Procedure C were incubated at 37 °C for 24 h, after which inserts were visually inspected and monolayer washed 3 times with 500 µL DPBS to remove non-adherent bacteria. GICs were then treated with 500 µL apical media containing 210 µM gentamycin sulfate and incubated at 37 °C for 45 min. GICs were washed four times with 500 µL DPBS to remove bacteria and residual antibiotic, followed by treatment with 500 µL DPBS with 0.1% Triton. GICs were placed on an orbital shaker shaking at 300 rpm for 20 min to lyse and lysates were serially diluted in MH broth and plated on MH agar containing appropriate selection antibiotics for colony counting.
Secreted mucin quantification by Alcian blue colorimetric assay
Secreted mucins in apical media collected from experiments were quantified via a colorimetric assay adapted from Hall et al (Hall Rl Fau -Miller et al.) . Briefly, collected samples stored in low-binding microcentrifuge tubes were spun at 6,000 x g for 5 min to pellet bacteria and/or cell debris prior to analysis. Supernatants were analyzed immediately or flash frozen with liquid nitrogen for storage at -80 °C. Samples were mixed with Alcian Blue solution (Richard Allan Scientific Co., San Diego, CA) in a ratio of 3:1 and incubated for 2 h. After, samples in 96well plates were centrifuged at 1,640 x g for 30 min at rt. Supernatants were removed by inversion and the resulting pellet resuspended twice with a 40% ethanol/60% 0.1M sodium acetate buffer with 25 mM MgCl2, pH 5.8, centrifuging 10 min as above after each resuspension. Washed pellets were fully dissolved in 10% SDS solution and absorption was measured at 620 nm on a plate reader (Spectramax m3/m2e). Mucin from bovine submaxillary glands (Sigma, Cat. No. M3895) served as a standard and was prepared and analyzed identically in parallel with experimental samples.
Fluorometric quantification of paracellular permeability in epithelial monolayers
Paracellular permeability of epithelial monolayers was quantified utilizing Lucifer Yellow reagent according to manufacturer's instructions. The epithelial monolayers of GICs were washed with transport buffer (HBSS with CaCl2, MgCl2 supplemented with 10 mM HEPES, pH 7.4) and 500 μl of 100 mM Lucifer Yellow in transport buffer was added to the apical compartment of each insert. Transport buffer (1.5 mL) was added to the basal compartment and inserts were incubated at 37 °C in 5% CO2 for 1-2 h with shaking. Following incubation, inserts were removed and 150 μl of each sample transferred to a 96-well plate and fluorescence measured (λex= 485 nm, λem= 530 nm.) Standard curves of Lucifer Yellow alone in transport buffer were generated to determine fluorophore concentrations in experimental samples. Apparent permeability coefficients were calculated according to manufacturer's instructions.
Quantification of cytokine/chemokine release by multiplexed immunoassay
Cytokine/chemokine amounts in apical or basal media samples collected from experiments were measured using E-cadherin cleavage assay with C. jejuni OMV The cleavage of recombinant E-cadherin was determined as described previously (Elmi et al. 2016) . Briefly, 10 µg of purified OMV was incubated with 1 µg of recombinant human E-cadherin containing a C-terminal 6xHis tag in PBS at 37 °C for 16 h. The reactions were mixed 1:1 with 2 x Laemmli buffer and boiled for 10 minutes. The samples were separated by SDS PAGE and transferred to nitrocellulose membrane by wet transfer. The membrane was blocked with 5% BSA in TBS for one h then incubated with mouse anti-His antibody overnight at 4 °C. The blot was incubated with anti-mouse secondary antibody at a 1:10,000 dilution for one h then imaged with LI-COR Odyssey scanner.
Barrier function characterization via transepithelial electrical resistance (TEER)
TEER measurement across epithelial monolayers in GIC transwells was carried out using EndOhm-12 chambers and an EVOM2 meter (World Precision Instruments, Sarasota, FL). Transwells and EndOhm chamber were maintained at 37 °C during all measurements to minimize variability. TEER of C2BBe1-only GICs in transwells (Day 21) was measured at the start of the experiment. Next, the apical media of the transwells was aspirated and replaced with 500 µL apical media alone or 500 µL containing 10 or 100 µg of wildtype or ΔpglE OMV. Transwells were incubated at 37 °C for 24 h, after which apical media was sampled and TEER measured a second time. Sampled media was flash frozen in liquid nitrogen for immunoassay analysis.
Statistical Analysis
All experiments were performed at least in triplicate, with additional replicates, technical replicates and independent biological replicates noted in each figure caption. Statistical analyses of data sets were performed using GraphPad Prism software. Statistical significance (P < 0.05) and P values were calculated utilizing Student's t-tests or 1-way ANOVA as appropriate.
